Evidence map›Paper›PMID 41059228›Full record

ArticleFrontiers in endocrinology2025

Risk factors for predicting lateral lymph node metastasis of papillary thyroid carcinoma based on LASSO-logistic regression.

Han Han, Lei Yang, WenJun Jia, Xiao Chen

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Han HanSchool of Nursing, Anhui University of Chinese Medicine, Hefei, China.
Lei YangThe Second Affiliated Hospital of Anhui Medical University, Hefei, China.
WenJun JiaThyroid surgery department, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Xiao ChenThyroid surgery department, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Many clinicians are facing the dilemma about whether therapeutic lateral lymph node dissection (LLND) should be applied to treat papillary thyroid carcinoma (PTC) patients with suspicious lateral lymph node metastasis (LLNM). This research plans to construct a model to predict the risk of LLNM in PTC patients. Methods: 389 PTC patients meeting the requirements were retrieved from the database of our hospital. The patients included were randomly divided into the training set (N1 = 244) and the validation set (N2 = 145). LASSO regression and logistic regression were used to screen the risk factors of LLNM. Receiver operating characteristic (ROC) curve, calibration curve and decision curve analysis (DCA) were used to measure the performance of the predictive model. Results: In this study, a predictive model for LLNM in PTC patients was established based on LASSO and logistic regression models. Nomogram was established for visualization. The analyses of the area under the curve (AUC), calibration curve and decision curve of the training set and validation set all performed well, indicating that the prediction model has net benefit and clinical practicability. Conclusions: Nomogram based on LASSO regression can predict the risk of preoperative LLNM in PTC patients. This model can assist doctors in formulating individualized postoperative follow-up plans for PTC patients.

Indexed as

Lymphatic MetastasisLymph NodesNomogramsThyroid Cancer, PapillaryThyroid NeoplasmsAdultAgedFemaleHumansLogistic ModelsLymph Node ExcisionMaleMiddle AgedPrognosisRetrospective StudiesRisk FactorsLASSOlateral lymph node metastasislogistic regressionnomogrampapillary thyroid carcinoma

Identifiers

PMID41059228
PMCPMC12497606

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.